Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity.

MLA

Pogacar, Ziva, et al. “Indisulam Synergizes with Palbociclib to Induce Senescence through Inhibition of CDK2 Kinase Activity.” PLoS ONE, vol. 17, no. 9, Sept. 2022, pp. 1–23. EBSCOhost, https://doi.org/10.1371/journal.pone.0273182.

APA

Pogacar, Z., Johnson, J. L., Krenning, L., De Conti, G., Jochems, F., Lieftink, C., Velds, A., Wardak, L., Groot, K., Schepers, A., Wang, L., Song, J.-Y., van de Ven, M., van Tellingen, O., Medema, R. H., Beijersbergen, R. L., Bernards, R., & Leite de Oliveira, R. (2022). Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity. PLoS ONE, 17(9), 1–23. https://doi.org/10.1371/journal.pone.0273182

Chicago

Pogacar, Ziva, Jackie L. Johnson, Lenno Krenning, Giulia De Conti, Fleur Jochems, Cor Lieftink, Arno Velds, et al. 2022. “Indisulam Synergizes with Palbociclib to Induce Senescence through Inhibition of CDK2 Kinase Activity.” PLoS ONE 17 (9): 1–23. doi:10.1371/journal.pone.0273182.